Section Arrow
Quote
QNRX.NASDAQ
- Quoin Pharmaceuticals Ltd
Quotes are at least 15-min delayed:2025/08/31 19:01 EDT
Regular Hours
Last
 7.3753
-0.1247 (-1.66%)
Day High 
7.6 
Prev. Close
7.5 
1-M High
8.27 
Volume 
1.91K 
Bid
7.37
Ask
7.85
Day Low
7.3753 
Open
7.52 
1-M Low
6.625 
Market Cap 
4.41M 
Currency USD 
P/E 0.01 
%Yield -- 
10-SMA 7.28 
20-SMA 7.19 
50-SMA 8.08 
52-W High 54.95 
52-W Low 5.01 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
958.65/-15.43
Enterprise Value
4.41M
Balance Sheet
Book Value Per Share
4.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CARMCarisma Therapeutics0.215-0.013-5.70%-- 
TNFATNF Pharmaceuticals Inc.0.0483-0.0133-21.59%-- 
ADAPAdaptimmune Therapeutics plc0.0589-0.01-14.51%-- 
SRPTSarepta Therapeutics18.2-0.14-0.76%15.76PE
OTLKOutlook Therapeutics0.8512-0.2388-21.91%0.58PE
Quotes are at least 15-min delayed：2025/08/31 19:01 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively havethe potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.